Company Overview and News

US Dollar at a 5-Month High, Gold at 5-Month Low

2018-05-22 marketrealist
Besides overall market volatility, the most important determinant of precious metal prices, especially gold’s (IAU) (SLV), is the US dollar. As gold prices reached a five-month low, the US dollar reached a five-month high against a basket of six major world currencies. The US dollar (UUP), as represented by the DXY Currency Index, has risen ~3.6% over the last month.

How Fall in Gold Prices Is Affecting Miners

2018-05-21 marketrealist
It seems that the rout in precious metals has also plagued the performance of precious metal mining companies. In this article, we’ll discuss Sibanye Gold (SBGL), Gold Fields (GFI), Yamana Gold (AUY), and Pan American Silver (PAAS), which have fallen 40.9%, 15.8%, and 10.3%, respectively. PAAS has risen 12.8% on a YTD basis.

Silver: The Second-Favorite Metal

2018-05-18 marketrealist
With continuing downward sentiment in precious metals, it’s important to look at what large traders and hedge funds are doing with their positions in metals. This article focuses on silver, which is predominantly a precious metal and acts as a buffer along with gold during market unrest. Silver was trading at $16.4 per ounce as of 9:00 AM. The resistance level for silver is at a 50-day moving average of $16.

Is It Time For Precious Metals Equities?  What About Barrick?

2018-05-17 seekingalpha
Precious metals stocks peaked in 2011, then bottomed in late 2015, ahead of the broader bottom in commodity equities.

Pan American Silver (PAAS) Q1 Earnings Top, Profits Up Y/Y

2018-05-15 zacks
Pan American Silver Corp. (PAAS - Free Report) logged a profit of $48.2 million or 31 cents per share for first-quarter 2018, marking a more than two-fold rise from the year-ago profit of $20 million or 13 cents per share. The results in the reported quarter include a $8 million gain from the company's sale of its full ownership of Minera Aquiline Argentina SA that owns the Calcatreu project in Argentina.

Can Silver Miners Rebound in 2018 after a Long Dry Spell?

2018-05-14 marketrealist
In 2017 and 2018 year-to-date, silver miners considerably underperformed silver. Miners are usually a leveraged play on metals, rising by a higher proportion when metal prices rise and falling harder when metal prices weaken. This trend hasn’t been visible lately as company-specific factors exerted more influence on stock prices.

5 Shining Silver Stocks to Buy Today | InvestorPlace

2018-05-11 investorplace
When it comes to precious metals, gold captures most of the spotlight. However, silver could be the real money metal in our current market. That’s because silver has the best of both worlds.

CANADA STOCKS - TSX rises 0.31 percent, lifted by Enbridge

2018-05-10 reuters
NEW YORK, May 10 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 48.69 points, or 0.31 percent, to 15,959.50. * The biggest contributor to the TSX gain was Enbridge, up 1.9 percent, to add 9.45 net index points after the pipeline company posted quarterly results and said it may sell more assets this year. Materials was the top sector contributor with a 15 net points boost.

Pan American Silver Corp. 2018 Q1 - Results - Earnings Call Slides

2018-05-10 seekingalpha
The following slide deck was published by Pan American Silver Corp. in conjunction with their 2018 Q1 earnings call.

How Precious Metals Are Moving in Relation to Core Indicators

2018-05-09 marketrealist
Gold and silver were marginally weak on Monday, May 7, declining 0.04% and 0.13%, respectively. Gold traded at $1,312.20 per ounce. Its RSI level has dropped to 30.0, which hints at a near-term reversal in its price. Its implied volatility remained at 9.1%.

Mining Stocks Q1 Earnings Roster for May 9: FNV, PAAS, AG

2018-05-08 zacks
Franco-Nevada Corporation price-eps-surprise | Franco-Nevada Corporation Quote The Zacks Consensus Estimate for the first-quarter 2018 is 29 cents, projecting 16% year-over-year growth.

Digging For Dividends Pt. 1: Pan American Silver Corporation

2018-05-07 seekingalpha
Pan American Silver is a world-class operator which boasts superb operational metrics and a pristine balance sheet.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 697900108